Viewing Study NCT07162051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-07-01 @ 2:43 AM
Study NCT ID: NCT07162051
Status: RECRUITING
Last Update Posted: 2025-09-09
First Post: 2025-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer
Sponsor: Xijing Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HR+/HER2- Early Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fuzaparib View
None breast cancer View